We caught up with Dr Bimal Shah at the ADA annual meeting in San Francisco to discuss Livongo’s latest study, which demonstrated that 94% of Livongo for Diabetes program Members who completed a program survey achieved improved Diabetes Empowerment Scale or Diabetes Distress Scale in year one of the Livongo for Diabetes Program.
1. What were the study findings? (0:05)
2. Can you explain the Diabetes Empowerment Scale-Short Form (DES-SF) and the Diabetes Distress Scale 2 (DDS2) and why they are significant? (0:47)
3. Can you tell me a bit more about the study details and participants? (2:10)
4. What else did you find impactful about the study? (2:49)
5. Why is it important for digital health companies to conduct research like this? (3:45)
Bimal Shah has no conflicts of interest in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Diabetes
Matthew Budoff, ENDO 2021: Findings from a Substudy of the VERTIS CV Trial – Ertugliflozin for T2DM & ASCVD
We caught up with Professor Matthew Budoff (UCLA and Lundquist Institute, Torrance, CA, US) to discuss ertugliflozin in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease inadequately controlled with metformin and sulfonylurea (Clinical Trial Identifier: NCT01986881). ‘Efficacy and Safety of Ertugliflozin in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease […]
Insulin at 100: a life-saving discovery but more remains to be done
2021 marks the centenary of the discovery of insulin. It is important to remind ourselves that this life-saving medication still remains beyond the reach of many people with diabetes who need it. Find out more at: https://worlddiabetesday.org/about/insulin-at-100/ Support: Published in collaboration with the International Diabetes Federation.
Juliana Chan, EASD 2020 – COVID-19 and type 1 diabetes
We spoke with Prof. Juliana Chan (The Chinese University of Hong Kong, Hong Kong) following her session on COVID-19 and the impact on patients with type 1 diabetes. Questions What key areas of diabetes and COVID-19 were discussed at EASD 2020? (0:05) How do you think the COVID-19 pandemic has affected treatment both now and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!